Diagnostic Value of Joint Detection of Serum TK1, TSGF, CA199, and CA724 for Gastric Cancer and Its Relationship With Clinicopathologic Features and Prognosis
The American Surgeon™ · 2025
DOI: 10.1177/00031348241307397 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, 2025. Verfasst von Aiwen Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, The Affiliated Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Antigens, Tumor-Associated, Carbohydrate, Thymidine Kinase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Objective
To assess the diagnostic value of joint detection of serum TK1, TSGF, CA199, and CA724 for gastric cancer and its relationship with clinicopathologic features and prognosis.
Methods
The 105 gastric cancer patients were enrolled. The diagnostic value of serum TK1, TSGF, CA199, and CA724 for gastric cancer and the relationship between these indicators and the clinicopathologic characteristics of gastric cancer patients were evaluated. During the follow-up period, recurrence, metastasis, and death were considered as poor prognosis. The relationships between serum TK1, TSGF, CA199, and CA724 levels and poor prognosis and factors affecting the poor prognosis of gastric cancer patients were analyzed.
Results
TK1, TSGF, CA199, and CA724 levels in the gastric cancer group were higher; serum TK1, TSGF, CA199, and CA724 levels were higher in gastric cancer patients with tumor diameters ≥3 cm, TNM stages III and IV, low/moderate degree of differentiation, infiltration depths of the muscular or plasma layer, and lymphatic metastases; AUC of combined TK1, TSGF, CA199, and CA724 (0.894) was higher than that of the four indicators alone; the percentage of gastric cancer patients with poor prognosis in patients with low serum TK1, TSGF, CA199, and CA724 levels was lower; serum TK1, TSGF, CA199, and CA724 levels were factors influencing poor prognosis of gastric cancer patients (all P < 0.05).
Conclusion
Elevated serum levels of TK1, TSGF, CA199, and CA724 are associated with clinicopathologic features and poor prognosis of gastric cancer and may be used as serum biomarkers for prognostic evaluation of gastric cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory, The Affiliated Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
- Department of Gastroenterology, The Affiliated Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Jishun Zhang
Zitieren
APA
Sun, A., Chen, H., Shi, X., Shang, Z., & Zhang, J. (2025). Diagnostic Value of Joint Detection of Serum TK1, TSGF, CA199, and CA724 for Gastric Cancer and Its Relationship With Clinicopathologic Features and Prognosis. The American Surgeon™. https://doi.org/10.1177/00031348241307397
Vancouver
Sun A, Chen H, Shi X, Shang Z, Zhang J. Diagnostic Value of Joint Detection of Serum TK1, TSGF, CA199, and CA724 for Gastric Cancer and Its Relationship With Clinicopathologic Features and Prognosis. The American Surgeon™. 2025. doi:10.1177/00031348241307397
BibTeX
@article{Sun2025,
author = {Sun, Aiwen and Chen, Hui and Shi, Xiaojuan and Shang, Zhanmin and Zhang, Jishun},
title = {Diagnostic Value of Joint Detection of Serum TK1, TSGF, CA199, and CA724 for Gastric Cancer and Its Relationship With Clinicopathologic Features and Prognosis},
journal = {The American Surgeon™},
year = {2025},
doi = {10.1177/00031348241307397}
}
EUVIMED